Acute supra-therapeutic oral terbutaline administration has no ergogenic effect in non-asthmatic athletes.

This study aimed to investigate the effects on a possible improvement in aerobic and anaerobic performance of oral terbutaline (TER) at a supra-therapeutic dose in 7 healthy competitive male athletes. On day 1, ventilatory threshold, maximum oxygen uptake [Formula: see text] and corresponding power output were measured and used to determine the exercise load on days 2 and 3. On days 2 and 3, 8 mg of TER or placebo were orally administered in a double-blind process to athletes who rested for 3 h, and then performed a battery of tests including a force-velocity exercise test, running sprint and a maximal endurance cycling test at Δ50 % (50 % between VT and [Formula: see text]). Lactatemia, anaerobic parameters and endurance performance ([Formula: see text] and time until exhaustion) were raised during the corresponding tests. We found that TER administration did not improve any of the parameters of aerobic performance (p > 0.05). In addition, no change in [Formula: see text] kinetic parameters was found with TER compared to placebo (p > 0.05). Moreover, no enhancement of the force-velocity relationship was observed during sprint exercises after TER intake (p > 0.05) and, on the contrary, maximal strength decreased significantly after TER intake (p < 0.05) but maximal power remained unchanged (p > 0.05). In conclusion, oral acute administration of TER at a supra-therapeutic dose seems to be without any relevant ergogenic effect on anaerobic and aerobic performances in healthy athletes. However, all participants experienced adverse side effects such as tremors.

Influence of early antioxidant supplements on clinical evolution and organ function in critically ill cardiac surgery, major trauma, and subarachnoid hemorrhage patients.

INTRODUCTION: Oxidative stress is involved in the development of secondary tissue damage and organ failure. Micronutrients contributing to the antioxidant (AOX) defense exhibit low plasma levels during critical illness. The aim of this study was to investigate the impact of early AOX micronutrients on clinical outcome in intensive care unit (ICU) patients with conditions characterized by oxidative stress. METHODS: We conducted a prospective, randomized, double-blind, placebo-controlled, single-center trial in patients admitted to a university hospital ICU with organ failure after complicated cardiac surgery, major trauma, or subarachnoid hemorrhage. Stratification by diagnosis was performed before randomization. The intervention was intravenous supplements for 5 days (selenium 270 microg, zinc 30 mg, vitamin C 1.1 g, and vitamin B1 100 mg) with a double-loading dose on days 1 and 2 or placebo. RESULTS: Two hundred patients were included (102 AOX and 98 placebo). While age and gender did not differ, brain injury was more severe in the AOX trauma group (P = 0.019). Organ function endpoints did not differ: incidence of acute kidney failure and sequential organ failure assessment score decrease were similar (-3.2 +/- 3.2 versus -4.2 +/- 2.3 over the course of 5 days). Plasma concentrations of selenium, zinc, and glutathione peroxidase, low on admission, increased significantly to within normal values in the AOX group. C-reactive protein decreased faster in the AOX group (P = 0.039). Infectious complications did not differ. Length of hospital stay did not differ (16.5 versus 20 days), being shorter only in surviving AOX trauma patients (-10 days; P = 0.045). CONCLUSION: The AOX intervention did not reduce early organ dysfunction but significantly reduced the inflammatory response in cardiac surgery and trauma patients, which may prove beneficial in conditions with an intense inflammation. TRIALS REGISTRATION: Clinical Trials.gov RCT Register: NCT00515736.

Prevalence of methadone injection in three Swiss cities.

OBJECTIVE: Intravenous methadone is associated with increased risk of morbidity and mortality. A previous report from a methadone center in Fribourg, Switzerland, found a high prevalence (43%) of patients who injected oral methadone. We therefore wished to assess the prevalence of methadone injection among patients in oral methadone programs in 3 other Swiss cities--Lausanne, Geneva, and La Chaux-de-Fonds. METHOD: Subjects were randomly selected and interviewed by assistant psychologists who were not on the staff of the study centers. Participation was voluntary and anonymous. RESULTS: 164 patients participated in the study (n = 58 in Lausanne, 52 in Geneva, and 54 in La Chaux-de-Fonds). The prevalence of methadone injection was low (5%) and did not differ significantly between the cities. DISCUSSION: Less liberal policies cannot explain the lower prevalence of methadone injection in these three centers than in Fribourg. The high prevalence of methadone injection there is probably related to its separate methadone injection program: patients in oral methadone programs may be more likely to injection methadone when other patients authorized to do so. IN CONCLUSION: Although the 5% prevalence of methadone injection found in the 3 cities surveyed is low, it is not negligible. These results suggest that information on the risks associated with injection of methadone syrup should be provided to all methadone maintenance. This information is especially necessary when maintenance therapy is provided in the same center, or city as injectable methadone maintenance.

Pharmacodynamic and humoral effects of single intravenous doses of captopril in normal subjects.

The blood pressure, heart rate and humoral responses to single intravenous doses of the angiotensin converting enzyme inhibitor captopril were evaluated in 5 volunteers on a free salt intake. Each subject was given at one-week intervals a 1, 5 and 25 mg intravenous dose of captopril as well as the vehicle of captopril. The study was conducted in a single-blind fashion and the order of treatment phases was randomized. Captopril was found to inhibit the renin-angiotensin system in a dose-dependent fashion. A fall in circulating angiotensin II was observed with doses of 1 and 5 mg. Plasma angiotensin II was not detectable 15 min after the 25 mg dose. Acute inhibition of angiotensin converting enzyme with intravenous captopril had no effect on blood pressure and heart rate.

Vaccinia immune globulin: current policies, preparedness, and product safety and efficacy.

In 1980 the World Health Organization declared that smallpox was eradicated from the world, and routine smallpox vaccination was discontinued. Nevertheless, samples of the smallpox virus (variola virus) were retained for research purposes, not least because of fears that terrorist groups or rogue states might also have kept samples in order to develop a bioweapon. Variola virus represents an effective bioweapon because it is associated with high morbidity and mortality and is highly contagious. Since September 11, 2001, countries around the world have begun to develop policies and preparedness programs to deal with a bioterror attack, including stockpiling of smallpox vaccine. Smallpox vaccine itself may be associated with a number of serious adverse events, which can often be managed with vaccinia immune globulin (VIG). VIG may also be needed as prophylaxis in patients for whom pre-exposure smallpox vaccine is contraindicated (such as those with eczema or pregnant women), although it is currently not licensed in these cases. Two intravenous formulations of VIG (VIGIV Cangene and VIGIV Dynport) have been licensed by the FDA for the management of patients with progressive vaccinia, eczema vaccinatum, severe generalized vaccinia, and extensive body surface involvement or periocular implantation following inadvertent inoculation.

Intranasal administration of the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei with the modified heat-labile toxin of Escherichia coli (LTK63) induces a complete protection against malaria challenge.

Needle-free procedures are very attractive ways to deliver vaccines because they diminish the risk of contamination and may reduce local reactions, pain or pain fear especially in young children with a consequence of increasing the vaccination coverage for the whole population. For this purpose, the possible development of a mucosal malaria vaccine was investigated. Intranasal immunization was performed in BALB/c mice using a well-studied Plasmodium berghei model antigen derived from the circumsporozoite protein with the modified heat-labile toxin of Escherichia coli (LTK63), which is devoid of any enzymatic activity compared to the wild type form. Here, we show that intranasal administration of the two compounds activates the T and B cell immune response locally and systemically. In addition, a total protection of mice is obtained upon a challenge with live sporozoites.

Délégation de compétences et répartition des tâches au sein du conseil d'administration : rôles du conseil d'administration, de ses comités et de l'assemblée générale

Introduction générale : Depuis peu, la colère gronde au sein des actionnaires. Certains d'entre eux s'estiment écartés à tort de certaines décisions importantes et se plaignent de ne pouvoir exercer aucune influence sur la façon dont est gérée la société, dont ils sont pourtant propriétaires. Ce sentiment d'impuissance et même d'injustice est exacerbé par l'octroi, à certains dirigeants parfois peu scrupuleux, de rémunérations astronomiques et en décalage avec les résultats obtenus. Bien que l'assemblée générale soit, aux termes de l'art. 698 al. 1 CO, le pouvoir suprême de la société, les administrateurs et les directeurs donnent l'impression d'être omnipotents et exempts de toute responsabilité Certains actionnaires estiment en d'autres termes que les sociétés anonymes souffrent d'un manque de contrôle. Ce sentiment correspond-il à la réalité ? Notre étude tente de répondre à cette question en examinant l'éventuel rapport hiérarchique entre l'assemblée générale et le conseil d'administration, les devoirs de ce dernier, les conditions auxquelles il peut déléguer la gestion, enfin, la responsabilité de ses membres. Face à l'ampleur du sujet, nous avons été contraint d'effectuer des choix, forcément arbitraires. Nous avons décidé d'écarter la problématique des groupes de sociétés. De même, les législations sur les bourses, les banques et les fusions ne seront que mentionnées. Signalons enfin que certaines problématiques abordées par notre étude occupent actuellement le législateur. Nous avons dès lors tenu compte des travaux préparatoires effectués jusqu'à la fin de l'année 2008. Nous commencerons par étudier dans une première partie les relations et l'éventuel rapport hiérarchique entre l'assemblée générale, pouvoir suprême de la société, et le conseil d'administration, chargé d'exercer la haute direction et de gérer les affaires de la société. La détermination de leurs positions hiérarchiques respectives devrait nous permettre de savoir si et comment l'assemblée générale peut s'immiscer dans les compétences du conseil d'administration. Nous nous intéresserons ensuite à la gestion de la société, le législateur postulant qu'elle doit être conjointement exercée par tous les membres du conseil d'administration dans la mesure où elle n'a pas été déléguée. Or, comme un exercice conjoint par tous les administrateurs ne convient qu'aux plus petites sociétés anonymes, la gestion est très fréquemment déléguée en pratique. Nous examinerons ainsi les conditions formelles et les limites matérielles de la délégation de la gestion. Nous étudierons en particulier les portées et contenus respectifs de l'autorisation statutaire et du règlement d'organisation, puis passerons en revue la liste de compétences intransmissibles et inaliénables du conseil d'administration dressée par l'art. 716a al. 1 CO. Nous nous attarderons ensuite sur les différents destinataires de la délégation en insistant sur la flexibilité du système suisse, avant de considérer la problématique du cumul des fonctions à la tête de la société, et de nous demander si la gestion peut être déléguée à l'assemblée générale. Nous conclurons la première partie en étudiant la manière dont l'assemblée générale peut participer à la gestion de la société, et exposerons à cet égard les récentes propositions du Conseil fédéral. Dans une deuxième partie, nous constaterons que face à l'ampleur et à la complexité des tâches qui lui incombent, il est aujourd'hui largement recommandé au conseil d'administration d'une grande société de mettre en place certains comités afin de rationnaliser sa façon de travailler et d'optimiser ainsi ses performances. Contrairement aux développements menés dans la première partie, qui concernent toutes les sociétés anonymes indépendamment de leur taille, ceux consacrés aux comités du conseil d'administration s'adressent principalement aux sociétés ouvertes au public et aux grandes sociétés non cotées. Les petites et moyennes entreprises seraient toutefois avisées de s'en inspirer. Nous traiterons de la composition, du rôle et des tâches de chacun des trois comités usuels que sont le comité de contrôle, le comité de rémunération et le comité de nomination. Nous exposerons à cet égard les recommandations du Code suisse de bonne pratique pour le gouvernement d'entreprise ainsi que certaines règles en vigueur en Grande-Bretagne et aux Etats-Unis, états précurseurs en matière de gouvernement d'entreprise. L'étude des tâches des comités nous permettra également de déterminer l'étendue de leur propre pouvoir décisionnel. Nous aborderons enfin la problématique particulièrement sensible de la répartition des compétences en matière de rémunération des organes dirigeants. Notre troisième et dernière partie sera consacrée à la responsabilité des administrateurs. Nous exposerons dans un premier temps le système de la responsabilité des administrateurs en général, en abordant les nombreuses controverses dont il fait l'objet et en nous inspirant notamment des récentes décisions du Tribunal fédéral. Comme la gestion n'est que rarement exercée conjointement par tous les administrateurs, nous traiterons dans un deuxième temps de la responsabilité des administrateurs qui l'ont déléguée. A cet égard, nous nous arrêterons également sur les conséquences d'une délégation ne respectant pas les conditions formelles. Nous terminerons notre travail par l'étude de la responsabilité des administrateurs en rapport avec les tâches confiées à un comité de conseil d'administration. Comme le conseil d'administration a des attributions intransmissibles et inaliénables et que les principes d'un bon gouvernement d'entreprise lui recommandent de confier certaines de ces tâches à des comités spécialisés, il s'agit en effet de déterminer si et dans quelle mesure une répartition des tâches au sein du conseil d'administration entraîne une répartition des responsabilités.

Effects of fructose on hepatic glucose metabolism in humans.

Hepatic and extrahepatic insulin sensitivity was assessed in six healthy humans from the insulin infusion required to maintain an 8 mmol/l glucose concentration during hyperglycemic pancreatic clamp with or without infusion of 16.7 micromol. kg(-1). min(-1) fructose. Glucose rate of disappearance (GR(d)), net endogenous glucose production (NEGP), total glucose output (TGO), and glucose cycling (GC) were measured with [6,6-(2)H(2)]- and [2-(2)H(1)]glucose. Hepatic glycogen synthesis was estimated from uridine diphosphoglucose (UDPG) kinetics as assessed with [1-(13)C]galactose and acetaminophen. Fructose infusion increased insulin requirements 2.3-fold to maintain blood glucose. Fructose infusion doubled UDPG turnover, but there was no effect on TGO, GC, NEGP, or GR(d) under hyperglycemic pancreatic clamp protocol conditions. When insulin concentrations were matched during a second hyperglycemic pancreatic clamp protocol, fructose administration was associated with an 11.1 micromol. kg(-1). min(-1) increase in TGO, a 7.8 micromol. kg(-1). min(-1) increase in NEGP, a 2.2 micromol. kg(-1). min(-1) increase in GC, and a 7.2 micromol. kg(-1). min(-1) decrease in GR(d) (P < 0. 05). These results indicate that fructose infusion induces hepatic and extrahepatic insulin resistance in humans.

Use of duplex ultrasonography in the treatment of thromboangiitis obliterans with iloprost.

We present a 34-year-old patient with digital necrosis due to thromboangiitis obliterans. He was successfully treated with iloprost, a prostaglandin analogue. Duplex ultrasonography was performed during the perfusion of iloprost to optimize the doses and the treatment duration. A complete revascularization was observed after 10 days. Iloprost perfusions were stopped, and a slow regression of the necroses was observed in the subsequent days. With the use of duplex ultrasonography, unnecessary high doses of iloprost and long periods of treatment can be avoided reducing side effects and treatment costs.

Kinetics of dexamethasone-induced alterations of glucose metabolism in healthy humans.

Six healthy human subjects were studied during three 75-g oral, [13C]glucose tolerance tests to assess the kinetics of dexamethasone-induced impairment of glucose tolerance. On one occasion, they received dexamethasone (4 x 0.5 mg/day) during the previous 2 days. On another occasion, they received a single dose (0. 5 mg) of dexamethasone 150 min before ingestion of the glucose load. On the third occasion, they received a placebo. Postload plasma glucose was significantly increased after both 2 days dexamethasone and single dose dexamethasone compared with control (P < 0.05). This corresponded to a 20-23% decrease in the metabolic clearance rate of glucose, whereas total glucose turnover ([6,6-2H]glucose), total (indirect calorimetry) and exogenous glucose oxidation (13CO2 production), and suppression of endogenous glucose production were unaffected by dexamethasone. Plasma insulin concentrations were increased after 2 days of dexamethasone but not after a single dose of dexamethasone. In a second set of experiments, the effect of a single dose of dexamethasone on insulin sensitivity was assessed in six healthy humans during a 2-h euglycemic hyperinsulinemic clamp. Dexamethasone did not significantly alter insulin sensitivity. It is concluded that acute administration of dexamethasone impairs oral glucose tolerance without significantly decreasing insulin sensitivity.